Elicio Therapeutics Statistics

Total Valuation

ELTX has a market cap or net worth of $126.42 million. The enterprise value is $113.86 million.

Market Cap	126.42M
Enterprise Value	113.86M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ELTX has 15.98 million shares outstanding. The number of shares has increased by 70.64% in one year.

Current Share Class	15.98M
Shares Outstanding	15.98M
Shares Change (YoY)	+70.64%
Shares Change (QoQ)	-5.13%
Owned by Insiders (%)	35.56%
Owned by Institutions (%)	17.93%
Float	10.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	14.19
P/TBV Ratio	14.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.65.

Current Ratio	1.83
Quick Ratio	1.61
Debt / Equity	0.65
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-76.44

Financial Efficiency

Return on equity (ROE) is -744.59% and return on invested capital (ROIC) is -216.68%.

Return on Equity (ROE)	-744.59%
Return on Assets (ROA)	-108.03%
Return on Invested Capital (ROIC)	-216.68%
Return on Capital Employed (ROCE)	-271.84%
Revenue Per Employee	n/a
Profits Per Employee	-$1.60M
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +133.33% in the last 52 weeks. The beta is 2.11, so ELTX's price volatility has been higher than the market average.

Beta (5Y)	2.11
52-Week Price Change	+133.33%
50-Day Moving Average	6.65
200-Day Moving Average	6.21
Relative Strength Index (RSI)	59.19
Average Volume (20 Days)	49,020

Short Selling Information

The latest short interest is 274,548, so 1.72% of the outstanding shares have been sold short.

Short Interest	274,548
Short Previous Month	168,478
Short % of Shares Out	1.72%
Short % of Float	2.67%
Short Ratio (days to cover)	6.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-45.48M
Pretax Income	-38.99M
Net Income	-51.28M
EBITDA	-45.19M
EBIT	-45.48M
Earnings Per Share (EPS)	-$3.98

Full Income Statement

Balance Sheet

The company has $18.35 million in cash and $5.79 million in debt, giving a net cash position of $12.56 million or $0.79 per share.

Cash & Cash Equivalents	18.35M
Total Debt	5.79M
Net Cash	12.56M
Net Cash Per Share	$0.79
Equity (Book Value)	8.90M
Book Value Per Share	0.56
Working Capital	9.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$35.07 million and capital expenditures -$87,000, giving a free cash flow of -$35.15 million.

Operating Cash Flow	-35.07M
Capital Expenditures	-87,000
Free Cash Flow	-35.15M
FCF Per Share	-$2.20

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-70.64%
Shareholder Yield	-70.64%
Earnings Yield	-40.56%
FCF Yield	-27.81%

Analyst Forecast

The average price target for ELTX is $9.50, which is 20.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.50
Price Target Difference	20.10%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-26.60%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1